Fenestrel
Fenestrel is a synthetic nonsteroidal estrogen that was developed in the 1960s. It is a member of the stilbestrol group of compounds and is structurally related to diethylstilbestrol (DES). Fenestrel was investigated for its potential use in hormone replacement therapy and as a contraceptive agent, but it was never marketed.
Chemical Structure and Properties[edit]
Fenestrel belongs to the class of synthetic estrogens known as stilbenes. Its chemical structure is characterized by two phenyl rings connected by an ethylene bridge, similar to other compounds in the stilbestrol group. The molecular formula of fenestrel is C20H20O2.
Pharmacology[edit]
Fenestrel acts as an agonist of the estrogen receptor, mimicking the effects of natural estrogens like estradiol. It binds to estrogen receptors in various tissues, including the uterus, breast, and bone, and can influence the growth and function of these tissues.
Medical Research and Applications[edit]
During its development, fenestrel was studied for several potential medical applications:
- Hormone replacement therapy: Fenestrel was evaluated for its ability to alleviate symptoms of menopause such as hot flashes and osteoporosis.
- Contraception: Researchers investigated fenestrel as a possible oral contraceptive due to its estrogenic activity.
Despite these investigations, fenestrel was never approved for clinical use, and its development was eventually discontinued.
Safety and Side Effects[edit]
As with other synthetic estrogens, concerns about the safety of fenestrel arose, particularly regarding its potential to cause carcinogenic effects similar to those observed with diethylstilbestrol (DES). Studies indicated that long-term use of synthetic estrogens could increase the risk of breast cancer and other estrogen-related cancers.
See Also[edit]
References[edit]
External Links[edit]
-
 | This medical article is a stub. You can help WikiMD by expanding the page. |
